-
Allergan's Chief R&D Officer Talks Avycaz, Assembly Biosciences And 6 'Potential Blockbusters' In The Pipeline
Monday, February 13, 2017 - 4:13pm | 718Early Monday, Allergan plc Ordinary Shares (NYSE: AGN) — one of the world's largest pharmaceutical companies that produces branded and generic drugs, and performs pharmaceutical research and development — announced its recent acquisition of Zeltiq Aesthetics. Benzinga had the privilege...
-
Actavis' Avycaz Delivers A One-Two Punch To Superbugs
Friday, March 6, 2015 - 3:15pm | 632Historically, the U.S. Food and Drug Administration has not exactly been a “speed demon” when it comes to approving new drugs. Thanks to the Generating Antibiotics Incentives Now (GAIN) Act and forward-thinking companies like Actavis plc (NYSE: ACT) that are taking advantage of that...